Nuvalent, Inc.
Pharmaceutical company · Cambridge, Massachusetts, United States · Nasdaq: NUVL
Nuvalent, Inc. is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2017. Its shares trade on Nasdaq under the ticker NUVL. It has reported private securities offerings to the US SEC, most recently $135 million sold in a notice filed in 2021.
Nuvalent at a glance
What does Nuvalent do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $135 million sold (2021).
Frequently asked questions about Nuvalent
Where is Nuvalent headquartered?
Nuvalent, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Nuvalent do?
Nuvalent, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Nuvalent a public company?
Yes. Nuvalent, Inc. trades on Nasdaq under the ticker NUVL.
When was Nuvalent founded?
The earliest incorporation on record for Nuvalent, Inc. is in 2017, according to public company registers.
Similar companies
- Spero Therapeutics, Inc.Cambridge, Massachusetts, United States
- Sarepta Therapeutics, Inc.Cambridge, Massachusetts, United States
- Alnylam Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
- Visterra, Inc.Cambridge, Massachusetts, United States
- Seres Therapeutics, Inc.Cambridge, Massachusetts, United States
- Merrimack Pharmaceuticals IncCambridge, Massachusetts, United States
- QurAlis CorpCambridge, Massachusetts, United States
- Apnimed, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.